Lexpos News

Community Pharmacy England today briefed Peers on the severe challenges facing community pharmacies, including the findings of the 2024 Pressures Survey. In a wide-ranging discussion, Peers were taken through findings on medicine supply issues, funding pressures, and pharmacy workforce shortages, as well as hearing about Pharmacy First. Chaired by former Pharmacy Minister Lord Hunt of [...]

The post Peers briefed on 2024 Pharmacy Pressures appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England, the Department of Health and Social Care (DHSC) has agreed that prescriptions requesting Azathioprine 50mg/5ml oral suspension (Special Order)  submitted as dispensed in February and March 2024 will be reimbursed based on the product endorsed. Prescriptions submitted as dispensed in February or March 2024 will  be reimbursed as [...]

The post Price adjustment for Azathioprine 50mg/5ml oral suspension (February and March 2024) appeared first on Community Pharmacy England.

The NHSmail team previously announced that multi-factor authentication (MFA) is set to become mandatory across the platform for all NHSmail users from later in 2024. What is MFA? Normally you use your email address and password to log into your NHSmail account. MFA is an additional security measure that verifies your identity when logging into your account. [...]

The post Reminder: NHSmail multi-factor authentication appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Humulin® S (insulin soluble human) 100units/ml solution for injection 10ml vials. This MSN is the second of two covering supply issues with insulin vials. The first MSN (MSN/2024/053) issued on 09/05/24 covered Humalog® vials. This MSN (MSN/2024/057) covers Humulin® S (insulin [...]

The post Medicine Supply Notification: Humulin® S (insulin soluble human) 100units/ml solution for injection 10ml vials appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Trazodone hydrochloride 50mg/5ml oral solution (Cygnus Pharma Ltd) Drug alert number: EL (24)A/16 Date issued: 20 May 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Trazodone hydrochloride 50mg/5ml oral solution (Cygnus Pharma Ltd) Company name: Cygnus Pharma Ltd Product name: [...]

The post MHRA Class 4 Medicines Notification: Trazodone hydrochloride 50mg/5ml oral solution (Cygnus Pharma Ltd) appeared first on Community Pharmacy England.